A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute Early Infection (ClinicalTria - Prime Network - Document - PDFSEARCH.IO

First Page	Meta Content
	A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection (ClinicalTria Add to Reading List Document Date: 2014-01-13 12:06:25 Open Document File Size: 1,59 MB Share Result on Facebook Company MD Laboratory / Profectus Biosciences Inc. / PhD Laboratory / / Event FDA Phase / / Facility PhD Laboratory of Immunoregulation/NIAID Investigational New Drug / / MedicalCondition HIV Infection / rebound viremia / infection / HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection / HIV / plasma viremia / HBV / HIV RNA / HCV / / MedicalTreatment antiretroviral therapy / / Organization National Institute of Health / Institution of cART / / Position Investigator / Principal Investigator / / Product IL-12 / Immunoregulation/NIAID Investigational New Drug / / Technology Electroporation / recombination / / SocialTag Health Vaccination HIV Vaccine Trials Network HIV DNA vaccination Antiretroviral drug Vaccine Long-term nonprogressor Zidovudine HIV/AIDS

A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection (ClinicalTriaAdd to Reading List